bioRxivCancer BiologyPreprint
Mechanisms of genomic instability dictate cytosolic DNA composition and dendritic cell mediated anti-tumor immunity
S. R. Mosley, A. Chen, D. N. Doell, S. Choi, C. Mowat, F. Meier-Stephenson, V. Meier-Stephenson, K. Baker
Abstract
Patients with microsatellite instable (MSI) colorectal cancers (CRC) face better prognosis than those with the more common chromosomal instable (CIN) subtype due to improved anti-tumor immune responses characterized by high cytotoxic T cell infiltration. Previous investigation identified the cytosolic DNA (cyDNA) sensor STING as necessary for chemokine-mediated T cell recruitment in MSI CRCs. Here, we find cyDNA from MSI CRC cells is inherently more capable of inducing STING activation and induces improved cytotoxic T cell activation by dendritic cells (DCs). Sequencing indicates MSI cyDNA is enriched for microsatellites, which upon DC uptake induce anti-tumor immunity in a manner consistent with clinical MSI CRCs. Radiation also modulates cyDNA stimulation capacity through larger cyDNA size and increased mitochondrial DNA content. Identifying highly stimulatory cyDNA arising from genomic instability such as in MSI CRCs allows for optimized development of DNA-based STING agonist therapies to improve responses of CIN CRC patients to immunotherapies.
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cytosolic DNA structures produced by mismatch-repair deficiency coordinate anti-tumor immunity in colorectal cancer
Shayla R. Mosley, Natalie Lapa, … Kristi Baker·Cell ReportsPeer-reviewed·Feb 19, 2026
- Antitumor immunity in dMMR colorectal cancers requires interferon-induced CCL5 and CXCL10
C. Mowat, S. R. Mosley, … K. Baker·bioRxiv·Sep 15, 2020
- cGAS/STING and NLRP3 cooperatively activate CD8+ T cell-mediated anti-tumor immunity in colorectal cancer
C. Mowat, D. Schiller, K. Baker·bioRxiv·Aug 22, 2023
- STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
- Single cell spatial transcriptomics identifies coordinated cellular programs associated with good prognosis in microsatellite stable colorectal cancer
Victoria T. Karlsen, Umair Majid, … Frode Lars Jahnsen·bioRxiv·Mar 31, 2025
- Aberrant NOTUM+ Program Induced in LGR5+ Crypt Base Columnar Cells Maintains an Immunosuppressive Niche in Colorectal Cancer
Julian Chua, Parnika Sakthivel, … Arshad Ayyaz·bioRxiv·Mar 10, 2025